Low-dose UVA 1 phototherapy for scleroderma: What benefit can we expect?

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 5, 2012, Pages 619-626

  Pereira, N ^a   Santiago, F ^a   Oliveira, H ^a   Figueiredo, A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MORPHEA; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCLERODERMA; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET A1 RADIATION;

ADOLESCENT; ADULT; AGED; CHILD; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOTHERAPY; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84857576743     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04137.x     Document Type: Article

References (35)

1. Jaworsky C,. Connective tissue diseases. In, Elder D, Elenitsas R, Jaworsky C, Johnson B Jr, eds. Lever's Histopathology of the Skin, 8th edn. Lippincott-Raven Publishers, Philadelphia, 1997: 253-285.
2. Badea I, Taylor M, Rosenberg A, et al. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology (Oxford) 2009; 48: 213-221.
3. Sapadin AN, Esser AC, Fleischmajer R,. Immunopathogenesis of scleroderma evolving concepts. Mt Sinai J Med 2001; 68: 233-242.
4. Peterson LS, Nelson AM, Su WPD,. Classification of morphea (localized scleroderma). Mayo Clin Proc 1995; 70: 1068-1076.
5. Rowell NR, Goodfield MJD,. The connective tissue diseases. In:, Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, Vol. 3. Blackwell Scientific Publications, Oxford, UK, 1992: 2163-2194.
6. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-944. (Pubitemid 27265906)
7. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA1 phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26. (Pubitemid 28100460)
8. Clements PJ, Lachenbruch PA, Ng SC, et al. Skin score: a semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis. Arthritis Rheum 1990; 33: 1256-1263. (Pubitemid 20273315)
9. Hulshof MM, Bouwes Bavinck JN, Bergman W, et al. Double-blind, placebo controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 2000; 43: 1017-1023.
10. Rodnan GP, Lipinski I, Luksick J,. Skin collagen content in progressive systemic sclerosis (scleroderma) and localized scleroderma. Arthritis Rheum 1979; 22: 130-140. (Pubitemid 9156666)
11. Takeda K, Hatamochi A, Ueki H, et al. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103: 359-363. (Pubitemid 24329757)
12. Rowell NR, Goodfield MJD,. The connective tissue diseases. In, Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology, Vol. 3. Blackwell Scientific Publications, Oxford, UK, 1992: 2225-2266.
13. de Rie MA, Enomoto DNH, de Vries HJC, et al. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003; 207: 298-301. (Pubitemid 37329201)
14. Sator PG, Radakovic S, Schulmeister K, et al. Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment. J Am Acad Dermatol 2009; 60: 786-791.
15. Suh KS, Kang JS, Baek JW, et al. Efficacy of ultraviolet A1 phototherapy in recalcitrant skin diseases. Ann Dermatol 2010; 22: 1-8.
16. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-1768. (Pubitemid 27506289)
17. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
18. Petersen MJ, Hansen C, Craig S,. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 1992; 99: 440-444.
19. Wlaschek M, Briviba K, Stricklin GP, et al. Singlet oxygen may mediate the ultraviolet A induced synthesis of interstitial collagenase. J Invest Dermatol 1995; 104: 194-198.
20. Gruss C, Reed JA, Altmeyer P, et al. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997; 350: 1295-1296. (Pubitemid 28036641)
21. Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 2004; 50: 740-747. (Pubitemid 38580553)
22. Durand F, Staumont D, Bonnevalle A, et al. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis. Photodermatol Photoimmunol Photomed 2007; 23: 215-221. (Pubitemid 350055608)
23. Morita A, Kobayashi K, Isomura I, et al. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000; 43: 670-674.
24. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-1896. (Pubitemid 24031593)
25. Kerscher M, Volkenandt M, Meurer M, et al. Treatment of localised scleroderma with UVA bath photochemotherapy. Lancet 1994; 343: 1233. (Pubitemid 24147585)
26. Kerscher M, Dirschka T, Volkenandt M,. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
27. Dawe RS,. Ultraviolet A phototherapy. Br J Dermatol 2003; 148: 626-637.
28. Rombold S, Lobisch K, Katzer K, et al. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatol Photoimmunol Photomed 2008; 24: 19-23.
29. Kreuter A, Hyund J, Stücker M, et al. A randomized controlled study of low-dose UVA, medium-dose UVA and narrowband UVB phtototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006; 54: 440-447. (Pubitemid 43243447)
30. Strober BE,. Generalized morphea. Dermatol Online J 2003; 9: 24.
31. Neustadter MD, Frank Samarin MD, Kacie R., et al. Extracorporeal photochemotherapy for generalized deep morphea Jason H. Arch Dermatol 2009; 145: 127-130.
32. Martini G, Ramanan AV, Falcini F, et al. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology 2009; 48: 1410-1413.
33. Leitenberger JJ, Cayce RL, Haley RW, et al. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermato 2009; 14: 545-550.
34. 1 phototherapy for proximal and acral scleroderma in systemic sclerosis. Photodermatol Photoimmunol Photomed 2009; 25: 153-155.
35. Gazi H, Pope JE, Clements P, et al. Outcome measurements in scleroderma: results from a delphi exercise. J Rheumatol 2007; 34: 501-509. (Pubitemid 46364004)